An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Enrolling by invitation · NCT07217860 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE) | Bipolar and Related Disorders, bipolar I disorder, bipolar II disorder, bipolar disorder, mood disorder, psychiatric disorder | Enrolling by invitation | Phase 3 | 2026-09-02 | NCT07217860 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xenon Pharmaceuticals Inc. | 9 |
20 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.